Submit Deal

23ANDME INC

HQ - San Francisco, California

Summary

23andMe offers DNA testing with the most comprehensive ancestry breakdown, personalized health insights and more.

Deals Overview

Total Deals5

Valued Deals4

Total Value£ 3.27 B

Avg. Deal Size£ 818 M

Market Context

Senior Management

Joe Selsavage
Interim CEO
Steve Schoch
CFO
Jacquie Haggarty
In-house Counsel

Sort

04 Feb 2021|United States|Biotechnology

Target: 23ANDME INC

Bidder: VG ACQUISITION CORP

11 Service Providers

5 Target | 6 Bidder

39 Dealmakers

24 Target | 16 Bidder

£ 2.56 B

Value

22 Oct 2021|United States|Pharmaceuticals

Target: LEMONAID HEALTH

Bidder: 23ANDME INC

7 Service Providers

3 Target | 4 Bidder

20 Dealmakers

17 Target | 3 Bidder

£ 289 M

Value

18 Apr 2024|United States|Biotechnology

Target: 23ANDME INC

Bidder: ANNE WOJCICKI

5 Service Providers

4 Target | 1 Bidder

10 Dealmakers

8 Target | 2 Bidder

n/a

Value

19 May 2025|United States|Biotechnology

Target: 23ANDME INC

Bidder: REGENERON

6 Service Providers

4 Target | 2 Bidder

26 Dealmakers

7 Target | 19 Bidder

£ 192 M

Value

13 Jun 2025|United States|Biotechnology

Target: 23ANDME INC

Bidder: TTAM RESEARCH INSTITUTE

13 Service Providers

7 Target | 6 Bidder

11 Dealmakers

2 Target | 10 Bidder

£ 224 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy